glutamine 1ml glutathione 1ml Compounded Injection PFKFB3 activates CAD to enhance

BPC-157 neuroprotective effects were demonstrated within 30 seconds of administration in the ischemia model

For BPC-157, the FDA explicitly classified the compound as an "unapproved drug," and US regulatory authorities issued warnings on so-called "wellness" products containing it

Every batch includes: HPLC purity analysis chromatographic confirmation of 99% single-peak purity Mass spectrometry identity verification confirming the correct 1,419.53 Da molecular weight Amino acid analysis sequence verification of the 15-residue GEPPPGKPADDAGLV sequence QR code COA verification every product vial includes a QR code linking to the lot-specific COA, enabling point-of-use analytical verification BPC-157 is available in research-ready lyophilized format

Overall, these findings highlight the promising yet preliminary nature of BPC-157 and TB-500 research and reinforce the urgent need for standardized, large-scale clinical trials and robust safety monitoring frameworks before these compounds can be confidently integrated into clinical practice